International Journal of Drug Policy
Volume 21, Issue 3 , Pages 179-185 , May 2010

Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks

  • Pedro Mateu-Gelabert

      Affiliations

    • National Development Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 845 4572; fax: +1 917 438 0894.
    • ,
  • Milagros Sandoval

      Affiliations

    • National Development Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, United States
    • ,
  • Peter Meylakhs

      Affiliations

    • Centre for Independent Social Research, P.O.B. 193, 191040, Ligovsky prospect 87, Office 301, St. Petersburg, Russia
    • Tel.: +7 812 71837 96; fax: +7 812 71837 96.
    • ,
  • Travis Wendel

      Affiliations

    • National Development Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, United States
    • ,
  • Samuel R. Friedman

      Affiliations

    • National Development Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, United States

Received 20 October 2008 ,Revised 17 June 2009 ,Accepted 7 August 2009.

References 

  1. Bourgois P. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco Shooting Encampments. Substance Use & Misuse. 1998;33:2323–2351
  2. Booth DJ, Baker R. The impact of self-presentation and interviewer bias effects on self-reported heroin use. Addiction. 1987;82:8
  3. Brand S, Price R. The economic and social costs of crime. London: Home Office; 2000;
  4. Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health. 1991;81:1291–1295
  5. Connors MM. Risk perception, risk taking and risk management among intravenous drug users: Implications for AIDS prevention. Social Science & Medicine. 1992;34:591–601
  6. Connors MM. Stories of pain and the problem of AIDS prevention: Injection drug withdrawal and its effect on risk behavior. Medical Anthropology Quarterly. 1994;8:47–68
  7. Craine N, Walker M, Carnwath T, Klee H. Hepatitis C testing and injecting risk behaviour: The results of a UK based pilot study. International Journal of Drug Policy. 2004;15:115–122
  8. Des Jarlais DC, Perlis T, Arasteh K, Torian L, Hagan H, Beatrice S, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19:S20–S25
  9. Friedman SR, Mateu-Gelabert P, Sandoval M, Hagan H, Des Jarlais DC. Positive deviance control–case life history: A method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health. 2008;8:94
  10. Friedman, S. R., Sandoval, M., Mateu-Gelabert, P., Meylakhs, P., Des Jarlais, D.C. (in press). Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Substance Use & Misuse.
  11. Glaser BG. Basics of grounded theory analysis: Emergence vs. forcing. Mill Valley, CA: Sociology Press; 1992;
  12. Godfrey C, Eaton G, McDougall C, Culyer A. The economic and social costs of Class A drug use in England and Wales. London: Home Office; 2000;
  13. Gordon D, Dahl J. Fast fact and concept #95. Opioid withdrawal. 2nd ed.. End-of-Life/Palliative Education Resource Center; 2007;Retrieved October 1, 2008 from www.eperc.mcw.edu
  14. Gossop M, Griffiths P, Powis B, Strang J. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care. 1993;5:159–168http://www.informaworld.com/smpp/title∼db=all∼content=t713403300∼tab=issueslist∼branches=5 - v52
  15. Grund JP. Drug use as a social ritual: Functionality, symbolism and determinants of self-regulation. Rotterdam: Instituut voor Verslavingsonderzoek Hammersley; 1993;
  16. Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science & Medicine. 1996;42(5):691–703
  17. Grund JP, Kaplan CD, Adriaans NF. Needle sharing in The Netherlands: An ethnographic analysis. American Journal of Public Health. 1991;81(12):1602–1607
  18. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. The Journal of Infectious Diseases. 2002;186:1558–1564
  19. Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. The Mount Sinai Journal Of Medicine. 2000;67:5–6
  20. Hagan H, Des Jarlais DC, Stern R, Lelitiu-Weinberger C, Scheinmann R, Strauss S. HCV synthesis project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy. 2007;18:341–351
  21. Hughes RA. “When you’re using gear you put HIV to the back of your mind and forget about it”: Constructs of risk. Journal of Psychoactive Drugs. 2004;36:357–366
  22. Judd A, Hickman M, Jones S, McDonald T, Parry J, Stimson G. Incidence of hepatitis C virus and HIV among new injecting drug users in London—Prospective cohort study. British Medical Journal. 2005;330:24–25
  23. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviours among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;12:202–207
  24. Leshner, A. (2000). Oops: how casual drug use leads to addiction. U.S. Department of Health and Human Services, National Institutes of Health. Retrieved January 15, 2009 from http://www.nida.nih.gov/Published_Articles/Oops.html.
  25. Maher L, Jiong L, Jalaludin B, Chant K, Kaldor J. High hepatitis C incidence in new injecting drug users: A policy failure?. Australian and New Zealand Journal of Public Health. 2007;31:30–35
  26. Mateu-Gelabert P, Maslow C, Flom PL, Sandoval M, Bolyard M, Friedman SR. Keeping it together: Stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care. 2005;17:802–813
  27. Mateu-Gelabert P, Treloar C, Agullo V, Sandoval M, Valderrama JC, Maher L, et al. How can hepatitis C be prevented in the long-term?. International Journal of Drug Policy. 2007;18:338–340
  28. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: Risk reduction is not enough. AIDS. 2007;21:1967–1969
  29. Plumridge E, Chetwynd J. The moral universe of injecting drug users in the era of AIDS: Sharing injecting equipment and the protection of moral standing. Aids Care. 1998;10(6):723–733
  30. Rhodes T, Treloar C. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction. 2008;103:1593–1603
  31. Ross MW, Wodak A, Stowe A, Gold J. Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction. 1994;89:473–479
  32. Shewan D, Dalgarno P, Marshall A, Lowe E, Campbell M, Nicholson S, et al. Patterns of heroin use among a non-treatment sample in Glasgow (Scotland). Addiction Research. 1998;6(3):215–234
  33. Smolka M, Schmidt LG. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999;94:1191–1198
  34. Stein MD, Dubyak P, Herman D, Anderson BJ. Perceived barriers to safe injection practices among drug injectors who remain HCV-negative. The American Journal of Drug and Alcohol Abuse. 2007;33:517–525
  35. Sternin J, Choo R. The power of positive deviance. Harvard Business Review. 2000;14–15
  36. Strang J, Griffiths P, Gossop M. Heroin smoking by ‘chasing the dragon’: Origins and history. Addiction. 1997;92:673–683
  37. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893
  38. Volkow, N. (2008). Director's Message to Medical and Health Professionals. U.S. Department of Health and Human Services, National Institutes of Health. Retrieved January 15, 2009 from http://www.nida.nih.gov/about/welcome/medstaffmessage.html.
  39. Warburton H, Turnbull PJ, Hough M. Occasional and controlled heroin use. Not a problem?. York: Joseph Rowntree Foundation; 2005;
  40. Wray J. Can we learn from successful mothers?. Journal of Tropical Pediatrics and Environmental Child Health. 1972;18:279
  41. Zeitlin M, Ghassemi H, Mansour M. Positive deviance in child nutrition—With emphasis on psychosocial and behavioral aspects and implications for development. Tokyo: United Nations University Press; 1990;
  42. Zinberg N. Drug, set and setting—The basis for controlled intoxicant use. New Haven and London: Yale University Press; 1984;

PII: S0955-3959(09)00111-X

doi: 10.1016/j.drugpo.2009.08.007

International Journal of Drug Policy
Volume 21, Issue 3 , Pages 179-185 , May 2010

Article Tools